Literature DB >> 20367294

Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts.

Mary Kay Washington1, Jordan Berlin, Philip A Branton, Lawrence J Burgart, David K Carter, Carolyn C Compton, Wendy L Frankel, J Milburn Jessup, Sanjay Kakar, Bruce Minsky, Raouf E Nakhleh, Jean-Nicolas Vauthey.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20367294     DOI： 10.5858/134.4.e14

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  15 in total

1.  Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival.

Authors:  Sun Mi Lee; Matthew H G Katz; Li Liu; Manonmani Sundar; Hua Wang; Gauri R Varadhachary; Robert A Wolff; Jeffrey E Lee; Anirban Maitra; Jason B Fleming; Asif Rashid; Huamin Wang
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

2.  A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.

Authors:  Huabang Zhou; Xiaolan Jiang; Qiaomei Li; Jingyi Hu; Zhengrong Zhong; Hao Wang; Hui Wang; Bing Yang; Heping Hu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.

Authors:  Jose M Pimiento; Dung-Tsa Chen; Barbara A Centeno; Ashley H Davis-Yadley; Kazim Husain; William J Fulp; Chen Wang; Anying Zhang; Mokenge P Malafa
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

4.  Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans.

Authors:  Artit Jirapatnakul; Anthony P Reeves; Sara Lewis; Xiangmeng Chen; Teng Ma; Rowena Yip; Xing Chin; Shuang Liu; Ponni V Perumalswami; David F Yankelevitz; Michael Crane; Andrea D Branch; Claudia I Henschke
Journal:  Eur J Radiol       Date:  2019-10-25       Impact factor: 3.528

5.  Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.

Authors:  Sara Lewis; Cecilia Besa; Mathilde Wagner; Kartik Jhaveri; Shingo Kihira; Hongfa Zhu; Nima Sadoughi; Sandra Fischer; Amogh Srivastava; Eric Yee; Koenraad Mortele; James Babb; Swan Thung; Bachir Taouli
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

6.  Histological classification of liver and intrahepatic bile duct cancers in SEER registries.

Authors:  Sean F Altekruse; Susan S Devesa; Lois A Dickie; Katherine A McGlynn; David E Kleiner
Journal:  J Registry Manag       Date:  2011

7.  The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection.

Authors:  Daniel J Kagedan; Ravish S Raju; Matthew E Dixon; Elizabeth Shin; Qing Li; Ning Liu; Maryam Elmi; Abraham El-Sedfy; Lawrence Paszat; Alexander Kiss; Craig C Earle; Nicole Mittmann; Natalie G Coburn
Journal:  HPB (Oxford)       Date:  2016-02-09       Impact factor: 3.647

Review 8.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

9.  Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer.

Authors:  Annika Eurola; Ari Ristimäki; Harri Mustonen; Anna-Maria Nurmi; Jaana Hagström; Caj Haglund; Hanna Seppänen
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

10.  Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.

Authors:  Matthew H G Katz; Fang-Shu Ou; Joseph M Herman; Syed A Ahmad; Brian Wolpin; Robert Marsh; Spencer Behr; Qian Shi; Michael Chuong; Lawrence H Schwartz; Wendy Frankel; Eric Collisson; Eugene J Koay; JoLeen M Hubbard; James L Leenstra; Jeffrey Meyerhardt; Eileen O'Reilly
Journal:  BMC Cancer       Date:  2017-07-27       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.